Just to clarify - nothing physical prevents re-use, just the law - and if the end-user breaks the law, they're liable, NOT the manufacturer. ...So we have to trust our own doctors, and that the system will work.
...Is this the enzyme, do you think?
Seven years in development sounds right. ...But is it commercially available yet?
IMHO - we're better off with instruments like the NanoKnife that aren't re-used and don't rely on sterilization.
San Jose Man Makes Cross-Continental Journey for IRE Treatment of Pancreatic Cancer
Newswise Published: September 03, 2010
Life was good for 64 year-old Jerry Gates, a San Jose plant rental company owner. He had two grown children, Tyler 32 and Jessica, 29, who adored him, a wife with whom in August this year he celebrated his 40th year of marriage, and a thriving business that allowed them to live a very comfortable lifestyle in the self-proclaimed capital of Silicon Valley.
That bubble quickly burst on March 15, when…... The surgeon reviewing the case explained the full extent of the biopsy results - inoperable stage IV pancreatic cancer. He then told Jerry to "get his affairs in order because he did not have long to live."
He came back to Stony Brook to have the procedure done on July 21st. When Dr. Watkins walked into his room the following Friday afternoon, he was amazed.
"This looks like a man who hasn't had surgery," he said.
Dr. Watkins did use the NanoKnife on Jerry Gates to address the tumor cells.
NanoKnife at Piedmont Hospital
Piedmont Hospital is one of a few healthcare facilities in the world to offer one of the newest weapons for fighting cancer — NanoKnife. Our specially trained physicians use this new minimally invasive treatment to destroy soft-tissue tumors, particularly those that have spread to the liver, kidneys, lungs and prostate.
How the NanoKnife System Works
NanoKnife uses a targeted approach to treating small, hard-to-reach tumors at the cellular level. Performed under general anesthesia, our specially trained physicians insert electrodes into or around the tumor using a CT scan or ultrasound imaging as a guide. By applying a series of short, intense electrical pulses directly into the tumor, irreversible damage is caused to the cells. The cancer cells die and the healthy tissue remains unharmed. Because there are few side effects or scarring, treatments can be repeated if new lesions develop.
Who is a candidate for NanoKnife?
NanoKnife can be an effective treatment option for patients who have tumors less than five centimeters that are inoperable or when radiation therapy is not advised.
Benefits of NanoKnife
Physicians can treat inoperable tumors
Patients undergo general anesthesia and experience little pain following the procedure.
Treatment requires only a brief hospital stay. Patients are typically discharged from the hospital the day following the procedure.
With few side effects or scarring, the procedure can be repeated if new lesions develop.
Link to article
Link to hospital
Local Hospital Targets Previously Inoperable Tumors
DAYTON — Miami Valley Hospital recently began offering a new cancer treatment technology that it claims is the first of its kind in the state.
The hospital in mid-September began using the NanoKnife IRE system, which doctors say will help them completely remove primary tumors that previously had been either inoperable or could only be partially removed due to their proximity to vital organs or blood vessels.
The hospital used $300,000 from its foundation to pay for the technology, for which patients previously had to travel to Louisville. The hospital expects to do at least 30 NanoKnife procedures in the next year.
The device targets tumors through a specialized ablation procedure that causes a tumor to kill itself off and be removed by the body’s own lymphatic system.
The procedure involves a series of needlelike probes with an electrical generator, a computer with a monitor, and foot pedals that operate it. Electrical pulses poke multiple holes in a tumor’s cellular walls, causing it to die naturally and be discarded by the body.